Status:
NOT_YET_RECRUITING
Atrial Fibrillation Ablation and Autonomic Modulation Via Thoracoscopic Surgery, 10 Year Follow up.
Lead Sponsor:
Amsterdam UMC
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
This observational study investigates the long-term outcomes of patients ten years after their participation in a previous study on the surgical treatment of atrial fibrillation (AF). Participants wer...
Detailed Description
Rationale: Invasive treatment of atrial fibrillation (AF) has a limited efficacy. A substantial group of patients keep having symptoms of AF after ablation. Autonomic modulation of AF through ablation...
Eligibility Criteria
Inclusion
- AFACT Trial participant
Exclusion
- Refusal to be contacted for future studies during or since the AFACT trial.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06493591
Start Date
September 1 2024
End Date
August 1 2025
Last Update
July 12 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.